1. Home
  2. RGEN vs QRVO Comparison

RGEN vs QRVO Comparison

Compare RGEN & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • QRVO
  • Stock Information
  • Founded
  • RGEN 1981
  • QRVO 1957
  • Country
  • RGEN United States
  • QRVO United States
  • Employees
  • RGEN N/A
  • QRVO N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • QRVO Semiconductors
  • Sector
  • RGEN Health Care
  • QRVO Technology
  • Exchange
  • RGEN Nasdaq
  • QRVO Nasdaq
  • Market Cap
  • RGEN 8.0B
  • QRVO 6.6B
  • IPO Year
  • RGEN N/A
  • QRVO 1997
  • Fundamental
  • Price
  • RGEN $118.07
  • QRVO $76.14
  • Analyst Decision
  • RGEN Buy
  • QRVO Hold
  • Analyst Count
  • RGEN 12
  • QRVO 19
  • Target Price
  • RGEN $172.67
  • QRVO $89.89
  • AVG Volume (30 Days)
  • RGEN 791.0K
  • QRVO 1.9M
  • Earning Date
  • RGEN 04-29-2025
  • QRVO 07-29-2025
  • Dividend Yield
  • RGEN N/A
  • QRVO N/A
  • EPS Growth
  • RGEN N/A
  • QRVO N/A
  • EPS
  • RGEN N/A
  • QRVO 0.58
  • Revenue
  • RGEN $650,429,000.00
  • QRVO $3,718,971,000.00
  • Revenue This Year
  • RGEN $13.93
  • QRVO $0.54
  • Revenue Next Year
  • RGEN $14.35
  • QRVO $5.19
  • P/E Ratio
  • RGEN N/A
  • QRVO $131.07
  • Revenue Growth
  • RGEN 4.88
  • QRVO N/A
  • 52 Week Low
  • RGEN $102.97
  • QRVO $49.46
  • 52 Week High
  • RGEN $182.52
  • QRVO $130.99
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.80
  • QRVO 53.75
  • Support Level
  • RGEN $120.55
  • QRVO $73.00
  • Resistance Level
  • RGEN $123.71
  • QRVO $77.75
  • Average True Range (ATR)
  • RGEN 4.63
  • QRVO 1.88
  • MACD
  • RGEN -0.58
  • QRVO -0.53
  • Stochastic Oscillator
  • RGEN 7.59
  • QRVO 26.76

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

Share on Social Networks: